introduction: pseudomonas aeruginosa is one of the leading causes of nosocomial infections, and antibiotic resistance of this pathogen is an important concern in treating such infections. the current work was conducted to investigate the prevalence of bla-imp, and bla-vim metallo-beta-lactamase (mbl) among clinical and environmental p. aeruginosa isolates obtained from icus of different hospita...

background one of the major clinical problems regarding pseudomonas aeruginosa is attributed to metallo-beta-lactamases (mbl). this group of enzymes is a subset of beta lactamases which belong to group b of ambler classification and cause hydrolysis of carbapenems. based on epidemiological studies conducted worldwide, it is proved that prevalence of genes coding mbls in p. aeruginosa species ar...

Metallo-beta-lactamase production is an important mechanism for carbapenem resistance of Pseudomonas aeruginosa , which represents an emerging public health challenge. We report the case of a patient admitted to an intensive care unit, with sepsis caused by multidrug-resistant São Paulo Metallo-beta-lactamase-1-producing P. aeruginosa . This is the first case of infection by this pathogenic str...

results the most effective agent against the studied isolates was colistin. by cddt, it was found that among 278 imipenem resistant p. aeruginosa strains, 178(64.02%) were mbl producers. the blaimp-1 and blavim-1 genes were detected in 30(16.8%) and 52(29.2%) of p. aeruginosa isolates, respectively. result of 187 imipenem resistance a. baumannii strains showed that 85(45.4%) were mbl producers....

conclusions the inter- and intra-hospital dissemination of resistant clones is a matter of concern and is an indicator of the level of the improvement and surveillance of standard hygiene, particularly disinfection and hand washing before and after contact with patients. given the emergence of mbl-producing strains, surveillance has become an important procedure to control the transmission of r...

background metallo-beta-lactamase (mbl) producing pseudomonas aeruginosa in the burn patients is a leading cause of morbidity and mortality and remains a serious health concern among the clinicians. objectives the aim of this study was to detect mbl-producing p. aeruginosa in burn patients and determine multidrug-resistant (mdr) strains, and respective resistance patterns. patients and methods ...

The blaIMP gene coding for the IMP-1 metallo-beta-lactamase produced by a Pseudomonas aeruginosa clinical isolate (isolate 101/1477) was overexpressed via a T7 expression system in Escherichia coli BL21 (DE3), and its product was purified to homogeneity with a final yield of 35 mg/liter of culture. The structural and functional properties of the enzyme purified from E. coli were identical to th...

Production of a metallo-beta-lactamase activity was detected in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate (isolate VR-143/97) from an Italian inpatient at the Verona University Hospital (northern Italy). The metallo-beta-lactamase determinant was isolated from a genomic library of VR-143/97, constructed in an Escherichia coli plasmid vector, by screening for clones with red...

Multidrug-resistant Pseudomonas aeruginosa nosocomial infections are increasingly recognized worldwide. The existence of metallo-beta-lactamase- and extended-spectrum beta-lactamase-producing isolates exhibiting resistance to most beta-lactam antimicrobial agents greatly complicates the clinical management of patients infected with such isolates. Since 1998, P. aeruginosa isolates resistant to ...

Six strains of multidrug-resistant Stenotrophomonas maltophilia were isolated from cultured yellowtail. The strains were divided into two clusters based on the 16S rRNA genes, and all of them contained L1 metallo-beta-lactamase and L2 beta-lactamase genes. Differences in the intercluster divergence between the lactamase genes suggest that horizontal transfer of the genes occurred.